Chemopreventive characteristics of avocado fruit

Seminars in Cancer Biology

Volumn 17, Issue 5, 2007, Pages 386-394

  Ding, Haiming ^a   Chin, Young Won ^b   Kinghorn, A Douglas ^b,c   D'Ambrosio, Steven M ^a,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Avocado; Cell signaling; Chemoprevention; Diet; Growth inhibition; Phytochemicals; Reactive oxygen species

Indexed keywords

APIGENIN; CHLOROFORM; LUTEOLIN; PERSEA AMERICANA EXTRACT; PERSIN; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; QUERCETIN; QUERCITRIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

APOPTOSIS; AVOCADO; CANCER INHIBITION; CANCER PREVENTION; CELL CYCLE ARREST; CONTROLLED STUDY; ETHNOBOTANY; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PHYTOCHEMISTRY; REVIEW; SIGNAL TRANSDUCTION;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL PROLIFERATION; CHEMOPREVENTION; FRUIT; HUMANS; NEOPLASMS; PERSEA; PLANT EXTRACTS;

EID: 34548458976     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2007.04.003     Document Type: Review

References (86)

1. La V., Altieri A., and Tavani A. Vegetables, fruit, antioxidants and cancer: a review of Italian studies. Eur J Nutr 40 (2001) 261-267
2. Vainio H., and Bianchini F. Evaluation of cancer-preventive agents and strategies: a new program at the International Agency for Research on Cancer. Ann NY Acad Sci 952 (2001) 177-180
3. Byers T.E. Nutrition and cancer: ten lessons from the 20th century. Nutrition 16 (2000) 561-563
4. DerMarderosian A., and Beutler J.A. Avocado. In: DerMarderosian A., and Beutler J.A. (Eds). The review of natural products: the most complete source of natural product information. 2nd ed. (2002), Lippincott Co., St. Louis: J.B. 63-64
5. Genus Persea. http://encyclopedia.thefreedictionary.com/genus+Persea.
6. Avocado varieties, avocado variety-California Avocado Commission. http://www.avocado.org/about/varieties.php.
7. Kashman Y., Neeman I., and Lifshitz A. New compounds from avocado pear. Tetrahedron 25 (1969) 4617-4631
8. Oberlies N.H., Rogers L.L., Martin J.M., and McLaughlin J.L. Cytotoxic and insecticidal constituents of the unripe fruit of Persea americana. J Nat Prod 61 (1998) 781-785
9. Rodriguez-Saona C., Millar J.G., and Trumble J.T. Isolation, identification, and biological activity of isopersin, a new compound from avocado idioblast oil cells. J Nat Prod 61 (1998) 1168-1170
10. Kawagishi H., Fukumoto Y., Hatakeyama M., He P., Arimoto H., Matsuzawa T., et al. Liver injury suppressing compounds from avocado (Persea americana). J Agric Food Chem 49 (2001) 2215-2221
11. Guevarra A.P., Espino M.P., Chua C., and Russel G. Anti-inflammatory principles of the leaves of Persea americana Mill. Philipp J Sci 127 (1998) 81-91
12. Abe F., Nagafuji S., Okawa M., Kinjo J., Akahane H., Ogura T., et al. Trypanocidal constituents in plants 5. Evaluation of some Mexican plants for their trypanocidal activity and active constituents in the seeds of Persea Americana. Biol Pharm Bull 28 (2005) 1314-1317
13. Oelrichs P.B., Ng J.C., Seawright A.A., Ward A., Schaffeler L., and MacLeod J.K. Isolation and identification of a compound from avocado (Persea americana) leaves which causes necrosis of the acinar epithelium of the lactating mammary gland and the myocardium. Nat Toxins 3 (1995) 344-349
14. Domergue F., Helms G.L., Prusky D., and Browse J. Antifungal compounds from idioblast cells isolated from avocado fruits. Phytochemistry 54 (2000) 183-189
15. Hashimura H., Ueda C., Kawabata J., and Kasai T. Acetyl-CoA carboxylase inhibitors from avocado (Persea americana Mill.) fruits. Biosci Biotechnol Biochem 65 (2001) 1656-1658
16. Carman R.M., and Handley P.N. Antifungal diene in leaves of various avocado cultivars. Phytochemistry 50 (1999) 1329-1331
17. Ramos M.R., Jerz G., Villanueva S., Lopez-Dellamary F., Waibel R., and Winterhalter P. Two glucosylated abscisic acid derivates from avocado seeds (Persea americana Mill. Lauraceae cv. Hass). Phytochemistry 65 (2004) 955-962
18. Murakoshi S., Isogai A., Chang C.-F., Kamikado T., Sakurai A., and Tamura S. The effects of two components from avocado leaves (Persea americana Mill.) and related compounds on the growth of silkworm larvae. Bombyx mori L Nippon Oyo Dobutsu Konchu Gakkaishi 20 (1976) 87-91
19. Rodriguez-Saona C.R., Maynard D.F., Phillips S., and Trumble J.T. Alkylfurans: effects of alkyl side-chain length on insecticidal activity. J Nat Prod 62 (1999) 191-193
20. Rodriguez-Saona C., Millar J.G., Maynard D.F., and Trumble J.T. Novel antifeedant and insecticidal compounds from avocado idioblast cell oil. J Chem Ecol 24 (1998) 867-889
21. Rodriguez-Saona C., Maynard D.F., Phillips S., and Trumble J.T. Avocadofurans and their tetrahydrofuran analogues: comparison of growth inhibitory and insecticidal activity. J Agric Food Chem 48 (2000) 3642-3645
22. Rodriguez-Saona C., and Trumble J.T. Biologically active aliphatic acetogenins from specialized idioblast oil cells. Curr Org Chem 4 (2000) 1249-1260
23. Merici F., Merici A.H., Yilmaz F., Yunculer G., and Yunculer O. Flavonoids of avocado (Persea americana) leaves. Acta Pharm Turc 34 (1992) 61-63
24. Wigg M.D., Al-Jabri A.A., Costa S.S., Race E., Bodo B., and Oxford J.S. In vitro virucidal and virustatic anti HIV-1 effects of extracts from Persea americana Mill. (avocado) leaves. Antivir Chem Chemother 7 (1996) 179-183
25. De Almeida A.P., Miranda M.M.F.S., Simoni I.C., Wigg M.D., Lagrota M.H.C., and Costa S.S. Flavonol monoglycosides isolated from the antiviral fractions of Persea americana (Lauraceae) leaf infusion. Phytother Res 12 (1998) 562-567
26. Matsusaka Y., Kawabata J., and Kasai T. Antioxidant constituents in avocado (Persea americana Mill.) seeds. Nippon Shoukuhin Kaegaku Kogaku Kaishi 50 (2003) 550-552
27. Ojewole J.A., and Amabeoku G.J. Anticonvulsant effect of Persea americana Mill. (Lauraceae) avocado leaf aqueous extract in mice. Phytother Res 20 (2006) 696-700
28. Kim H.W., Murakami A., Nakamura Y., and Ohigashi H. Screening of edible Japanese plants for suppressive effects on phorbol ester-induced superoxide generation in differentiated HL-60 cells and AS52 cells. Cancer Lett 176 (2002) 7-16
29. Khayyal M.T., and El-Ghazaly M.A. The possible "chondroprotective" effect of the unsaponifiable constituents of avocado and soya in vivo. Drugs Exp Clin Res 24 (1998) 41-50
30. Werman M.J., and Neeman I M.S. Partial isolation and characterization of a new natural inhibitor of lysyl oxidase from avocado seed oil. J Agric Food Chem 38 (1990) 2164-2166
31. Kut-Lasserre C., Miller C.C., Ejeil A.L., Gogly B., Dridi M., Piccardi N., et al. Effect of avocado and soybean unsaponifiables on gelatinase A (MMP-2), stromelysin 1 (MMP-3), and tissue inhibitors of matrix metalloproteinase (TIMP-1 and TIMP-2) secretion by human fibroblasts in culture. J Periodontol 72 (2001) 1685-1694
32. Pei X.H., and Xiong Y. Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene 24 (2005) 2787-2795
33. Brown L., Boswell S., Raj L., and Lee S.W. Transcriptional targets of p53 that regulate cellular proliferation. Crit Rev Eukaryot Gene Expr 17 (2007) 73-85
34. Dong Y., Sui L., Tai Y., Sugimoto K., and Tokuda M. The overexpression of cyclin-dependent kinase (CDK) 2 in laryngeal squamous cell carcinomas. Anticancer Res 21 (2001) 103-108
35. Ding H., Han C., Gibson-D'Ambrosio R., Steele V.E., and D'Ambrosio S.M. Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1. Int J Cancer 107 (2003) 830-836
36. Quon H., Liu F.F., and Cummings B.J. Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck 23 (2001) 147-159
37. Liu S.C., and Klein-Szanto A.J. Markers of proliferation in normal and leukoplakic oral epithelia. Oral Oncol 36 (2000) 145-151
38. Narayanan B.A. Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets. Curr Cancer Drug Targets 6 (2006) 711-727
39. Gibbs E., Pan Z., Niu H., and Hurwitz J. Studies on the in vitro phosphorylation of HSSB-p34 and-p107 by cyclin-dependent kinases. Cyclin-substrate interactions dictate the efficiency of phosphorylation. J Biol Chem 271 (1996) 22847-22854
40. Wall M.E., Wani M.C., Brown D.M., Fullas F., Oswald J.B., Josephson F.F., et al. Effect of tannins on screening of plant extracts for enzyme inhibitory activity and techniques for their removal. Phytomedicine 3 (1996) 281-285
41. Kinghorn A.D., Farnsworth N.R., Soejarto D.D., Cordell G.A., Swanson S.M., Pezzuto J.M., et al. Novel strategies for the discovery of plant-derived anticancer agents. Pharm Biol 41 (2003) 53-67
42. Butt A.J., Roberts C.G., Seawright A.A., Oelrichs P.B., MacLeod J.K., Liaw T.Y., et al. A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells. Mol Cancer Ther 5 (2006) 2300-2309
43. Casagrande F., and Darbon J.M. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem Pharmacol 61 (2001) 1205-1215
44. Kim D.H., Kim S.Y., Park S.Y., and Han M.J. Metabolism of quercitrin by human intestinal bacteria and its relation to some biological activities. Biol Pharm Bull 22 (1999) 749-751
45. Comalada M., Camuesco D., Sierra S., Ballester I., Xaus J., Galvez J., et al. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 35 (2005) 584-592
46. Lee T.J., Kim O.H., Kim Y.H., Lim J.H., Kim S., Park J.W., et al. Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells. Cancer Lett 240 (2006) 234-242
47. Vijayababu M.R., Kanagaraj P., Arunkumar A., Ilangovan R., Aruldhas M.M., and Arunakaran J. Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. J Cancer Res Clin Oncol 131 (2005) 765-771
48. Vijayababu M.R., Arunkumar A., Kanagaraj P., and Arunakaran J. Effects of quercetin on insulin-like growth factors (IGFs) and their binding protein-3 (IGFBP-3) secretion and induction of apoptosis in human prostate cancer cells. J Carcinog 5 (2006) 10
49. Vijayababu M.R., Arunkumar A., Kanagaraj P., Venkataraman P., Krishnamoorthy G., and Arunakaran J. Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Mol Cell Biochem 287 (2006) 109-116
50. Plaumann B., Fritsche M., Rimpler H., Brandner G., and Hess R.D. Flavonoids activate wild-type p53. Oncogene 13 (1996) 1605-1614
51. Beniston R.G., and Campo M.S. Quercetin elevates p27(Kip1) and arrests both primary and HPV16 E6/E7 transformed human keratinocytes in G1. Oncogene 22 (2003) 5504-5514
52. van Erk M.J., Roepman P., van der Lende T.R., Stierum R.H., Aarts J.M., van Bladeren P.J., et al. Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr 44 (2005) 143-156
53. Ma Z.S., Huynh T.H., Ng C.P., Do P.T., Nguyen T.H., and Huynh H. Reduction of CWR22 prostate tumor xenograft growth by combined tamoxifen-quercetin treatment is associated with inhibition of angiogenesis and cellular proliferation. Int J Oncol 24 (2004) 1297-1304
54. Ranelletti F.O., Maggiano N., Serra F.G., Ricci R., Larocca L.M., Lanza P., et al. Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumors. Int J Cancer 85 (2000) 438-445
55. Psahoulia F.H., Moumtzi S., Roberts M.L., Sasazuki T., Shirasawa S., and Pintzas A. Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS transformed human colon cells. Carcinogenesis (2006)
56. Baliga B.C., and Kumar S. Role of Bcl-2 family of proteins in malignancy. Hematol Oncol 20 (2002) 63-74
57. Crompton M., Barksby E., Johnson N., and Capano M. Mitochondrial intermembrane junctional complexes and their involvement in cell death. Biochimie 84 (2002) 143-152
58. Fischer U., Janicke R.U., and Schulze O. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 10 (2003) 76-100
59. Kim R., Tanabe K., Uchida Y., Emi M., Inoue H., and Toge T. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother Pharmacol 50 (2002) 343-352
60. Kiechle F.L., and Zhang X. Apoptosis: biochemical aspects and clinical implications. Clin Chim Acta 326 (2002) 27-45
61. Chen M., and Wang J. Initiator caspases in apoptosis signaling pathways. Apoptosis 7 (2002) 313-319
62. Parone P.A., James D., and Martinou J.C. Mitochondria: regulating the inevitable. Biochimie 84 (2002) 105-111
63. Chandra D., and Tang D.G. Mitochondrially localized active caspase-9 and caspase-3 result mostly from translocation from the cytosol and partly from caspase-mediated activation in the organelle. Lack of evidence for Apaf-1-mediated procaspase-9 activation in the mitochondria. J Biol Chem 278 (2003) 17408-17420
64. Kim J.S., He L., and Lemasters J.J. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 304 (2003) 463-470
65. Chang J., Hsu Y., Kuo P., Kuo Y., Chiang L., and Lin C. Increase of Bax/Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line. Life Sci 76 (2005) 1883-1893
66. Ferrer P., Asensi M., Priego S., Benlloch M., Mena S., Ortega A., et al. Nitric oxide mediates natural polyphenol-induced Bcl-2 down-regulation and activation of cell death in metastatic B16 melanoma. J Biol Chem 282 (2007) 2880-2890
67. Volate S.R., Davenport D.M., Muga S.J., and Wargovich M.J. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 26 (2005) 1450-1456
68. Szatrowski T.P., and Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51 (1991) 794-798
69. Trachootham D., Zhou Y., Zhang H., Demizu Y., Chen Z., Pelicano H., et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 10 (2006) 241-252
70. Schumacker P.T. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10 (2006) 175-176
71. Lee K.W., and Lee H.J. The roles of polyphenols in cancer chemoprevention. Biofactors 26 (2006) 105-121
72. Martin K.R. Targeting apoptosis with dietary bioactive agents. Exp Biol Med 231 (2006) 117-129
73. Sheu S.S., Nauduri D., and Anders M.W. Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim Biophys Acta 1762 (2006) 256-265
74. Engel R.H., and Evens A.M. Oxidative stress and apoptosis: a new treatment paradigm in cancer. Front Biosci 11 (2006) 300-312
75. Kizaki M., Xian M., Sagawa M., and Ikeda Y. Induction of apoptosis via the modulation of reactive oxygen species (ROS) production in the treatment of myeloid leukemia. Curr Pharm Biotechnol 7 (2006) 323-329
76. Giles G.I. The redox regulation of thiol dependent signaling pathways in cancer. Curr Pharm Des 12 (2006) 4427-4443
77. Adachi M., Sakamoto H., Kawamura R., Wang W., Imai K., and Shinomura Y. Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells. Histol Histopathol 22 (2007) 437-442
78. Simbula G., Columbano A., Ledda-Columbano G.M., Sanna L., Deidda M., Diana A., et al. Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells. Apoptosis 12 (2007) 113-123
79. Bayir H., Fadeel B., Palladino M.J., Witasp E., Kurnikov I.V., Tyurina Y.Y., et al. Apoptotic interactions of cytochrome c: redox flirting with anionic phospholipids within and outside of mitochondria. Biochim Biophys Acta 1757 (2006) 648-659
80. Huang H.L., Fang L.W., Lu S.P., Chou C.K., Luh T.Y., and Lai M.Z. DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation. Oncogene 22 (2003) 8168-8177
81. Ikeda T., Nakata Y., Kimura F., Sato K., Anderson K., Motoyoshi K., et al. Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid. Mol Cancer Ther 3 (2004) 39-45
82. Park S.J., Wu C.H., Gordon J.D., Zhong X., Emami A., and Safa A.R. Taxol induces caspase-10-dependent apoptosis. J Biol Chem 279 (2004) 51057-51067
83. Shakibaei M., Schulze-Tanzil G., Takada Y., and Aggarwal B.B. Redox regulation of apoptosis by members of the TNF superfamily. Antioxid Redox Signal 7 (2005) 482-496
84. Sandra F., Degli E.M., Ndebele K., Gona P., Knight D., Rosenquist M., et al. Tumor necrosis factor-related apoptosis-inducing ligand alters mitochondrial membrane lipids. Cancer Res 65 (2005) 8286-8297
85. Kim O.K., Murakami A., Takahashi D., Nakamura Y., Torikai K., Kim H.W., et al. An avocado constituent, persenone A, suppresses expression of inducible forms of nitric oxide synthase and cyclooxygenase in macrophages, and hydrogen peroxide generation in mouse skin. Biosci Biotechnol Biochem 64 (2000) 2504-2507
86. Harris G.K., Qian Y., Leonard S.S., Sbarra D.C., and Shi X. Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells. J Nutr 136 (2006) 1517-1521